Surgery Partners Inc’s Latest Session Shows Promising Results, Investors Advised to Analyze Stock Charts for Technical Perspective

October 17, 2024

☀️Trending News

Surgery Partners ($NASDAQ:SGRY) Inc is a leading healthcare services company that specializes in providing surgical and related ancillary services to patients and physicians. As a publicly traded company, its stock has been closely monitored by investors for its promising growth potential. In its latest session, Surgery Partners Inc showed promising results with a 0.41% outperformance. This may have caught the attention of investors who are looking for potential opportunities in the stock market.

However, it is important to note that while stock prices can indicate the overall performance of a company, it is also essential for investors to analyze stock chart patterns for technical guidance. Technical analysis involves studying charts and price movements to gain insights into the future direction of a stock’s price. By analyzing these patterns, investors can make more informed decisions about when to buy or sell a stock. In the case of Surgery Partners Inc, analyzing the stock chart patterns could provide valuable information about its potential future performance. For instance, if the stock has been consistently showing an uptrend and breaking through resistance levels, it could indicate a bullish signal, meaning that the stock price may continue to rise. On the other hand, if the stock has been experiencing a series of lower lows and highs, it could suggest a bearish signal, indicating a potential decline in the price. Analyzing stock chart patterns can also help investors identify key support and resistance levels, which can serve as important indicators for making trading decisions. Support levels refer to the price point at which a stock is expected to rebound after a decline, while resistance levels are price points at which a stock is expected to face selling pressure. In conclusion, while Surgery Partners Inc’s recent session may have shown promising results, investors are advised to analyze stock chart patterns for technical guidance. This can provide valuable insights into the potential future performance of the stock and guide investors in making informed decisions about their investments. As always, it is important for investors to conduct thorough research and consult with a financial advisor before making any investment decisions.

Price History

On Wednesday, investors in Surgery Partners Inc were greeted with promising results as the stock opened at $32.24 and closed at $32.68, reflecting a 2.51% increase from the previous closing price of $31.88. This indicates a strong buying interest in the stock, with investors showing confidence in the company’s future prospects. When analyzing the stock charts, it is important to look at key technical indicators such as moving averages, support and resistance levels, and trading volume. These indicators can provide valuable insight into the stock’s performance and help investors make informed decisions. In the case of Surgery Partners, its moving averages have been steadily increasing, indicating a bullish trend for the stock. The uptick in trading volume for Surgery Partners is also worth noting, as it suggests an increase in market activity and interest in the stock.

This could be attributed to positive news and developments surrounding the company, such as its recent acquisition of National Surgical Healthcare. Such acquisitions can often drive up a company’s stock price, making it an attractive investment opportunity. With an upward trend in its stock value and increased market activity, investors are advised to closely analyze the stock charts to make informed decisions about their investments. It will be interesting to see how Surgery Partners continues to perform in the coming days and weeks, and how this will impact its stock price in the long term. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Surgery Partners. More…

    Total Revenues Net Income Net Margin
    2.74k -11.9 3.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Surgery Partners. More…

    Operations Investing Financing
    293.8 -225.6 -155.2
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Surgery Partners. More…

    Total Assets Total Liabilities Book Value Per Share
    6.88k 3.51k 15.7
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Surgery Partners are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    13.8% 20.5% 12.0%
    FCF Margin ROE ROA
    7.5% 10.3% 3.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    After examining the financials of SURGERY PARTNERS, I have determined that the company is strong in assets and growth, with a medium level of profitability and weak dividend offerings. Based on these factors, I would classify SURGERY PARTNERS as a ‘cheetah’ company. This means that although they have achieved high revenue or earnings growth, they are considered less stable due to their lower profitability. Looking at the Star Chart, it is clear that SURGERY PARTNERS has a strong asset base. This is important for investors as it indicates that the company has valuable resources that can be used to generate future revenues. Additionally, the company’s growth potential is also promising, which may attract investors who are looking for long-term growth opportunities. However, it is worth noting that SURGERY PARTNERS falls short in terms of profitability and dividend offerings. This may not be appealing to investors who prioritize consistent returns or income from their investments. As a ‘cheetah’ company, SURGERY PARTNERS may be seen as a riskier investment compared to other companies with higher profitability. Despite these factors, SURGERY PARTNERS has a high health score of 8/10, indicating that it is capable of safely riding out any crisis without the risk of bankruptcy. This may make the company attractive to investors who prioritize stable and secure investments. Additionally, the company’s focus on the healthcare industry may also appeal to investors who are interested in socially responsible investments. In conclusion, investors who are interested in SURGERY PARTNERS may be those looking for long-term growth opportunities and are willing to take on some level of risk. The company’s strong asset base and growth potential make it an attractive option for those seeking high returns, while its high health score provides a sense of security for more conservative investors. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    It is one of the largest surgical providers in the country and faces competition from other providers such as Cross Country Healthcare Inc, Genesis Healthcare Inc, and PT Mitra Keluarga Karyasehat Tbk. All of these companies provide quality healthcare services for their respective markets and have an established presence in the surgical services sector.

    – Cross Country Healthcare Inc ($NASDAQ:CCRN)

    Cross Country Healthcare Inc is a leading provider of healthcare staffing and workforce solutions. With a market cap of 1.04 billion as of 2023, the company is well-positioned to capitalize on the growing demand for its services. Cross Country Healthcare Inc’s Return on Equity of 44.54% reflects the fact that the company is generating strong returns for its shareholders. The company offers a variety of solutions, from short-term staffing to long-term strategic workforce planning, that can help healthcare facilities optimize their staffing and operations. With its highly experienced team and industry-leading solutions, Cross Country Healthcare Inc is well positioned to continue to be a leader in the healthcare staffing space.

    – Genesis Healthcare Inc ($OTCPK:GENN)

    Genesis Healthcare Inc is a leading national provider of post-acute care services, offering long-term care and rehabilitation services at more than 500 skilled nursing centers and assisted/senior living communities in 34 states. As of 2023, the company has a market cap of 1.97M, indicating its relative small size compared to other healthcare providers. Despite its small size, Genesis Healthcare Inc has performed relatively well, evidenced by its Return on Equity of -2.17%. This metric is a measure of how much profit a company is able to generate from its shareholders’ investments, and a negative number indicates that the company is not generating a sufficient return on equity.

    – PT Mitra Keluarga Karyasehat Tbk ($IDX:MIKA)

    PT Mitra Keluarga Karyasehat Tbk is a leading provider of health and wellness services in Indonesia. The company has a current market cap of 42.7T, making it one of the largest companies in the country. PT Mitra Keluarga Karyasehat Tbk has achieved a remarkable 18.07% Return on Equity, which indicates that the company is able to generate a significant return on its shareholders’ equity. This demonstrates the company’s ability to efficiently manage its resources and generate a healthy return for its shareholders.

    Summary

    Surgery Partners Inc’s recent session showed positive performance, with a 0.41% increase.

    However, investors should not solely rely on this single reading and instead analyze stock chart patterns for a better understanding of the company’s performance. Technical analysis can provide valuable insights into the stock’s movement and potential future trends. It is important to consider various factors, such as market trends and company news, while making investment decisions. Investors should also take into account their risk tolerance and diversify their portfolio to mitigate potential losses. In conclusion, while Surgery Partners Inc may have shown a good session, thorough analysis is crucial for informed investing.

    Recent Posts

    Leave a Comment